Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
6
7
9
10
11
12
13
14
18
19
20
21
23
27
28
30
12:00 AM - Hepatology 2021
31
1
2
3
4
Heart Care and Diseases 2021
2021-03-03    
All Day
Euro Heart Conference 2020 will join world-class professors, scientists, researchers, students, Perfusionists, cardiologists to discuss methodology for ailment remediation for heart diseases, Electrocardiography, Heart Failure, [...]
Gastroenterology and Digestive Disorders
2021-03-04 - 2021-03-05    
All Day
Gastroenterology Diseases is clearing a worldwide stage by drawing in 2500+ Gastroenterologists, Hepatologists, Surgeons going from Researchers, Academicians and Business experts, who are working in [...]
Environmental Toxicology and Ecological Risk Assessment
2021-03-04 - 2021-03-05    
All Day
Environmental Toxicology 2021 you can meet the world leading toxicologists, biochemists, pharmacologists, and also the industry giants who will provide you with the modern inventions [...]
Dermatology, Cosmetology and Plastic Surgery
2021-03-05 - 2021-03-06    
All Day
Market Analysis Speaking Opportunities Speaking Opportunities: We are constantly intrigued by hearing from professionals/practitioners who want to share their direct encounters and contextual investigations with [...]
World Dental Science and Oral Health Congress
2021-03-08 - 2021-03-09    
All Day
About The Webinar Conference Series LLC Ltd invites you to attend the 42nd World Dental Science and Oral Health Congress to be held in March 08-09, 2021 with the [...]
Euro Metabolomics & Systems Biology
2021-03-08 - 2021-03-09    
All Day
Euro Metabolomics 2021 will be a platform to investigate recent research and advancements that can be useful to the researchers. Metabolomics is a rapidly emerging [...]
International Summit on Industrial Engineering
2021-03-15 - 2021-03-16    
All Day
Industrial Engineering conference invites all the participants to attend International summit on Industrial Engineering during March15-16, 2021 Webinar. This has prompt keynotes, Oral talks, Poster [...]
Digital Health 2021
2021-03-15 - 2021-03-16    
All Day
The use of modern technologies and digital services is not only changing the way we communicate, they also offer us innovative ways for monitoring our [...]
Genetics and Molecular biology 2021
2021-03-15    
All Day
Human genetics is study of the inheritance of characteristics by children from parents. Inheritance in humans does not differ in any fundamental way from that [...]
Food Science and Food Safety
2021-03-16 - 2021-03-17    
All Day
Food Safety. It also provides the premier multidisciplinary forum for researchers, professors and educators to present and discuss the most recent innovations, trends, and concerns, [...]
Traditional and Alternative Medicine
2021-03-16 - 2021-03-17    
All Day
Traditional Medicine 2021 welcomes attendees, presenters, and exhibitors from all over the world. We are glad to invite you all to attend and register for [...]
Carbon and Advanced Energy Materials
2021-03-16 - 2021-03-17    
All Day
Materials Science 2021 was an enchanted achievement. We give incredible credits to the Organizing Committee and participants of Materials Science 2021 Conference. Numerous tributes from [...]
Advancements in Tuberculosis and Lung Diseases
2021-03-17 - 2021-03-18    
All Day
Tuberculosis is a communicable disease, caused by the infectious bacterium Mycobacterium tuberculosis. It affects the lungs and other parts of the body (brain, spine). People [...]
Herbal Medicine and Acupuncture 2021
2021-03-22 - 2021-03-23    
All Day
The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and [...]
Hospital Management and Health Care
2021-03-22 - 2021-03-23    
All Day
Healthcare system refers to the totality of resource that a society distributes with in organization and health facilities delivery for the aim of upholding or [...]
Hematology and Infectious Diseases
2021-03-22 - 2021-03-23    
All Day
Hematology is the discipline concerned with the production, functions, bone marrow, and diseases which are related to blood, blood proteins. The main aim of this [...]
Aquaculture & Marine Biology
2021-03-24 - 2021-03-25    
All Day
The 15th International Conference on Aquaculture & Marine Biology is delighted to welcome the participants from everywhere the planet to attend the distinguished conference scheduled [...]
Artificial Intelligence & Robotics 2021
2021-03-24 - 2021-03-25    
All Day
The Conference Series LLC Ltd organizes conferences around the world on all computer science subjects including Robotics and its related fields. Here we are happy [...]
Tissue Engineering & Regenerative Medicine
2021-03-24 - 2021-03-25    
All Day
Tissue Engineering & Regenerative Medicine mainly focuses on Stem Cell Research and Tissue Engineering. Stem cell Research includes stem cell treatment for various disease and [...]
Nursing Research and Evidence Based Practice
2021-03-25 - 2021-03-26    
12:00 am
Global Nursing Practice 2021 has been circumspectly organized with various multi and interdisciplinary tracks to accomplish the middle objective of the gathering that is to [...]
Earth & Environmental Science 2021
2021-03-26 - 2021-03-27    
All Day
Earth Science 2021 is the integration of new technologies in the field of environmental science to help Environmental Professionals harness the full potential of their [...]
Earth & Environmental Science 2021
2021-03-26 - 2021-03-27    
All Day
Earth Science 2021 is the integration of new technologies in the field of environmental science to help Environmental Professionals harness the full potential of their [...]
Nanomaterials and Nanotechnology
2021-03-26 - 2021-03-27    
All Day
Nanomaterials are the elements which have at least one spatial measurement in the size range of 1 to 100 nanometre. Nanomaterials can be produced with [...]
Smart Materials and Nanotechnology
2021-03-29 - 2021-03-30    
All Day
Smart Material 2021 clears a stage to globalize the examination by introducing an exchange amongst ventures and scholarly associations and information exchange from research to [...]
World Nanotechnology Congress 2021
2021-03-29    
All Day
Nano Technology Congress 2021 provides you with a unique opportunity to meet up with peers from both academic circle and industries level belonging to Recent [...]
Nanomedicine and Nanomaterials 2021
2021-03-29    
All Day
NanoMed 2021 conference provides the best platform of networking and connectivity with scientist, YRF (Young Research Forum) & delegates who are active in the field [...]
Hepatology 2021
2021-03-30 - 2021-03-31    
All Day
Hepatology 2021 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range [...]
Events on 2021-03-03
Events on 2021-03-05
Events on 2021-03-17
Events on 2021-03-25
Events on 2021-03-30
Hepatology 2021
30 Mar 21
Articles

The New Crossroad: Interoperability, Meaningful Use Transformation, and Our Future

improving the health

By D’Arcy Guerin Gue, Director of Industry Relations, Phoenix Health Systems, Division of Medsphere Systems

Interoperability.

Achieving it is a predominant theme in healthcare today, and a priority agenda item ever since Meaningful Use (MU) incentives took over the industry in 2009. To clarify (from HIMSS), the definition of interoperability is “the ability of different information technology systems and software applications to communicate, exchange data, and use the information that has been exchanged.”

Interoperability sure sounds like the next step in Meaningful Use, achieving the ability to broadly aggregate and analyze health data and manage our population’s health, right? Yet, the industry seems to be at an impasse. What is holding it up?

Anyone who has observed the evolution of healthcare IT knows that our implementation cycle of major changes is long. Look at electronic transactions. HIPAA was passed in 1996, but it was 2003 before the standards were put in place, and well into the current decade before key payers could handle all the transactions. And, while claim and remittance advices gained universal acceptance fairly quickly, claim status transactions took much longer. Even today, 20 years after HIPAA was passed, hospitals must struggle with different payers that have implemented the standards in different ways.

The industry’s road to interoperability is paved with strikingly similar bumps and ruts. Some EHR  technologies are decades old, but implementation of EHRs only became mainstream when the federal government incentivized their use through the Meaningful Use program. Interoperability was a behind-the-scenes goal then,  but with certified EHRs now in place throughout the country, it’s a front and center concern. This is because interoperability is only practical if  EHR  usage has reached enough critical mass to make the possibilities realistic, including providing the basis for common standards for data sharing.

According to an ONC report to Congress on December 2015, there are still at least five powerful barriers that are preventing interoperability in healthcare management:

  • Lack of universal standards-based EHR systems’ adoption
  • Impact on providers’ day-to-day workflow
  • Complex privacy and security challenges associated with widespread HIE
  • Need for synchronous collective action among multiple stakeholders
  • Weak or misaligned incentives

This post will focus on perhaps the most problematical issues: the lack of universal standards across EHRs and their adoption, and weak or misaligned incentives.

All healthcare providers have not been equal under the Meaningful Use initiative. Many providers weren’t fortunate enough to be eligible for MU incentives, including long term care / post acute care facilities (LTPAC) and behavioral health providers. There are thousands of them, large and small. Both fields are making quantum leaps in growth, yet most continue to operate without even the most basic of EHRs (let alone ONC-certified systems).

But a strong relationship exists between behavioral health, LTCPA, and physical health, welfare, disease, and, ultimately, treatment. With the onset of the baby boomer “coming-of-age” era, this relationship is being strained as never before. A simple example: according to Mental Health America, more than two million of the 34 million Americans age 65 and older already suffer from some form of depression. Symptoms of clinical depression are often triggered by chronic physical illnesses common in later life, such as Alzheimer’s, Parkinson’s, heart disease, cancer and arthritis. Yet for all the investment put into MU-certified EHRs, hospital emergency rooms still have no access to the mental health records of a patient who arrives after taking a suicidal overdose of barbiturates.

The lack of information exchange capabilities between the MU incentives “haves” and “have-nots” has resulted in dysfunctional, even contradictory care programs for shared patients. For example, cardiac specialists prescribe beta-blockers for hypertension; psychiatrists recommend against them, knowing that notorious side effects of beta-blockers include depression and fatigue. The specialists have no access to others’ information. This problem is not different than in pre-MU years, but is much greater in magnitude, and creating increasing frustration across the provider community.  A resurgence of interest by Congress in these issues is afoot…but no decisive action seems imminent. In the meantime, this fragmentation of EHR users poses a significant barrier to nationwide interoperability.

The technical side of interoperability has been compromised by Meaningful Use’s profitability for vendors. Certainly, ONC has tightened the standards used by EHR systems, and has noted that one benefit is that “reporting to public health has expanded enormously across the country since it was included as a requirement in the EHR Incentive Programs.” But this remark is a tip-off on a major reason why EHR-to-EHR interoperability across providers has progressed slowly.  It was never a requirement of Meaningful Use.

The highly competitive EHR vendor industry has not been motivated to collaborate on technical standards for interoperability. Just the opposite. The EHR Incentive Program has been a bonanza for individual EHR vendors. Why would they compromise their profits by amping up technologies to share clients’ data with competitors?  In February, 2015, all five former and current ONC leaders came together to acknowledge and analyze this obstuctive factor in achieving interoperability.  In a an ONC Meeting, they decried the discontinuity between interoperability objectives and the stance of the vendor industry. Per Farzad Mostashari: “This [problem] is not because of the data standards, it’s because of the business practices…. Vendors haven’t been incentivized to make progress on interoperability and data sharing…. this is a market failure.” Should we be surprised?

In addition to the commerical barriers to adopting standards for exchanging clinical information, the current Meaningful Use technical standard, theConsolidated-Clinical Document Architecture (CDA) standard, isn’t sufficiently robust to handle the kinds of data needed in an interoperable environment.  The proposed Fast Healthcare Interoperability Resources (FHIR) standard would go a long way to making interoperability real. If you are inclined to find your way through these technical weeds, I recommend doing so.

Meaningful Use Stage 2 has not been a rousing success. A November 2015 Health Affairs report notes that while there has been a marked increase in hospitals’ ability to meet core Stage 2 MU criteria (40.5 percent of hospitals, up from 5.8 percent in 2013), this progress is “undoubtedly still much lower than the Centers for Medicare & Medicaid Services would’ve liked to see.” According to the report, “Hospitals most often reported up-front and ongoing costs, physician cooperation and complexity of meeting meaningful use criteria as challenges.”

The number of physician practices that have attested to Stage 2 is much lower. They have not kept up. Penalties started becoming part of their accounting considerations in 2014-2015 and have continued.  The Medical Group Management Association is concerned. “Those EPs [eligible professionals] who invested considerable resources in their Stage 1 certified EHR, many of them in small or rural clinical settings, are now in danger of falling behind.” While the details of these penalties are beyond the scope of this article, you can read more about them here.

This decreased momentum in following through on meeting Stage 2 EHR usage standards offers another signal that providers as a whole are not ready for interoperability and won’t be any time soon.

For the thousands in the healthcare industry that understand that the thrust of HIPAA was long term preparation for industry-wide interoperability of health data systems and resulting data aggregation and population health research and management, ONC’s Meaningful Use program has achieved significant progress.  It has not been a holy grail, but couldn’t have been considering inevitable roadblocks such as those discussed above.  Overall, ONC should be praised…MU has been a giant step in contributing to world wide healthcare advances.

Without substantial course corrections now to fast-forward interoperabiity, the industry risks setbacks in reaching long term goals that both the federal government and many healthcare providers have embraced. The latest announcements from ONC regarding an overhaul (or replacement) of the Meaningful Use program should be welcomed.

 

Rehab 4 Alcoholism is a helpline for people experiencing addiction. This helpline aims to stop addiction before it becomes too late. www.rehab4alcoholism.com 0800 111 4108